CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 49,383 shares (grant or award)
- 4 Grant or award Director acquired 49,383 shares (grant or award)
- 4 Grant or award Director acquired 49,383 shares (grant or award)
- 4 Grant or award Director acquired 49,383 shares (grant or award)
- 4 Grant or award Director acquired 49,383 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Grant or award Executive Vice Chairman acquired 454,153 shares (grant or award)
- 4 Grant or award PRESIDENT, CEO & CHAIRMAN acquired 454,153 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,000,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 2,625 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Open-market buy PRESIDENT, CEO & CHAIRMAN bought 763,359 shares at $1.84 ($1,404,581)
- 4 Open-market buy President, CEO & Chairman bought 5,000 shares at $7.48 ($37,418)
- 4 Open-market buy Chief Financial Officer bought 500 shares at $7.50 ($3,750)
- 4 Open-market buy President, CEO & Chairman bought 5,000 shares at $7.39 ($36,971)
- 4 Open-market buy President, CEO & Chairman bought 5,000 shares at $7.35 ($36,765)
- 4 Open-market buy President, CEO & Chairman bought 20,000 shares at $1.64 ($32,724)
- 4 Grant or award 10% owner acquired 575,191 shares (grant or award)
Page 2 of 15 · 289 filings